参考文献/References:
[1].胥雪莲,何川.炎症与动脉粥样硬化[J].心血管病学进展,2015,(5):634-637.
[2].Xiang WHu ZL,He XJ,et al.Intravenous transfusion of endothelial progenitor cells that overexpress vitamin D receptor inhibits atherosclerosis in apoE-deficient mice[J].Biomed Pharmacother,2016,84:1233-1242.
[3].Kiani A,Mohamadi-Nori E,Vaisi-Raygani A,et al.Vitamin D-binding protein and vitamin D receptor genotypes and 25-hydroxyvitamin D levels are associated with development of aortic and mitral valve calcification and coronary artery diseases[J].Mol Biol Rep,2019,46(5):5225-5236.
[4].[4] Dziedzic E,G?sior J,Paw?owski M,et al.Association of vitamin D deficiency and degree of coronary artery disease in cardiac patients with type 2 diabetes[J].J Diabetes Res,2017,2017:1-11.
[5].[5] Degerud E,Nygard O,de Vogel S,et al.Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris[J].J Clin Endocrinol Metab,2018,103(3):1161-1170.
[6].[6] Mirhosseini N,Rainsbury J,Kimball SM.Vitamin D supplementation,serum 25(OH)D concentrations and cardiovascular disease risk factors: a systematic review and meta-analysis[J].Front Cardiovasc Med,2018,5:87.
[7].[7] Sluyter JD,Camargo CA Jr,Stewart AW,et al.Effect of monthly,high-dose,long-term vitamin D supplementation on central blood pressure parameters: a randomized controlled trial substudy[J].J Am Heart Assoc,2017,6(10).pii: e006802.
[8].[8] Elenkova M,Tipton DA,Karydis A,et al.Vitamin D attenuates human gingival fibroblast inflammatory cytokine production following advanced glycation end product interaction with receptors for AGE[J].J Periodontal Res,2019,54(2):154-163.
[9].[9] Reiss AB,Miyawaki N,Moon J,et al.CKD,arterial calcification,atherosclerosis and bone health: Inter-relationships and controversies[J].Atherosclerosis,2018,278:49-59.
[10].[10] Iannuzzo G,Forte F,Lupoli R,et al.Association of vitamin D deficiency with peripheral arterial disease: a meta-analysis of literature studies[J].J Clin Endocrinol Metab,2018,103(6):2107-2115.
[11].[11] Saponaro F,Saba A,Frascarelli S,et?al.Vitamin D measurement and effect on outcome in a cohort of patients with heart failure[J].Endocr Connect,2018,7(9):957-964.
[12].[12] Costanzo S,de Curtis A,di Castelnuovo A,et?al.Serum vitamin D deficiency and risk of hospitalization for heart failure: Prospective results from the Moli-sani study[J].Nutr Metab Cardiovasc Dis,2018,28(3):298-307.
[13].[13] Liu X,Wang W,Tan Z,et?al.The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies[J].Nutr J,2019,18(1):73.
[14].[14] Canpolat U,Aytemir K,Hazirolan T,et al.Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation[J].J Cardiol,2017,69(1):16-23.
[15].[15] Manson JE,Cook NR,Lee IM,et al.Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease[J].N Engl J Med,2019,380(1):33-44.
[16].[16] Gaksch M,Jorde R,Grimnes G,et al.Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium[J].PLoS One,2017,12(2):e0170791.
[17].[17] Zhang R,Li B,Gao X,et al.Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies[J].Am J Clin Nutr,2017,105(4):810-819.
相似文献/References:
[1]赵丹 周鹏.达比加群及其逆转剂在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):801.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.034]
ZHAO DanZHOU Peng.Dabigatran and Reversal in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(8):801.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.034]
[2]陈元 楚天舒 武力勇.瘦素抵抗、瘦素受体基因多态性与冠状动脉粥样硬化性心脏病的相关性进展[J].心血管病学进展,2019,(8):1130.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.015]
CHEN Yuan,CHU Tianshu,WU Liyong.Leptin Resistance,Leptin Receptor Gene Polymorphism and Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):1130.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.015]
[3]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[4]孙涛 左权 周辉 刘安康 梁诚 汤圣兴.末梢桡动脉和无鞘技术在冠状动脉介入治疗中的应用现状[J].心血管病学进展,2020,(5):456.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.005]
[5]奚云萍 臧雁翔 李为民.临床SYNTAX计分及其衍生计分在冠心病血运重建预后中的应用价值[J].心血管病学进展,2020,(5):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
XI Yunping,ZANG Yanxiang,LI Weimin.Value of Clinical SYNTAX Score and Its Derivative Score in Prognosis of Coronary Artery Disease with Revascularization[J].Advances in Cardiovascular Diseases,2020,(8):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
[6]肖亚楠 高传玉 朱中玉.低剂量替格瑞洛在冠心病中的应用前景[J].心血管病学进展,2020,(7):706.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.009]
XIAO Yanan,GAO Chuanyu,ZHU Zhongyu.Application Prospects of Low-dose Ticagrelor in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2020,(8):706.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.009]
[7]李英 刘兴鹏.常见心血管病服药依从性[J].心血管病学进展,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
LI Ying,LIU Xingpeng.Medication Adherence For Common Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(8):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
[8]肖亚楠 高传玉.经皮冠脉介入术后短程双联抗血小板治疗的研究进展[J].心血管病学进展,2021,(4):318.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.008]
XIAO Yanan,GAO Chuanyu.Short-term Dual Antiplatelet Therapy after Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2021,(8):318.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.008]
[9]吉蓉 寿锡凌.秋水仙碱在冠状动脉粥样硬化性心脏病防治中的研究进展与争议[J].心血管病学进展,2022,(1):60.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.016]
JI Rong,SHOU Xiling.Research Progress and Controversy of Colchicine in Prevention and Treatment of Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(8):60.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.016]
[10]曾庆媛 文舒 吕瑜玫 王明义.维生素D及其代谢通路基因多态性与妊娠期高血压疾病相关性研究进展[J].心血管病学进展,2022,(11):1033.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.016]
ZENG Qingyuan,WEN Shu,LV Yumei,et al.The Correlation Between Vitamin D and Its Metabolic Pathway Gene Polymorphism and Hypertensive Disorder of Pregnancy[J].Advances in Cardiovascular Diseases,2022,(8):1033.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.016]